Search Results

There are 830 results for: content related to: Risk of adverse events following oseltamivir treatment in influenza outpatients, Vaccine Safety Datalink Project, 2007–2010

  1. Adverse drug events in patients admitted to an emergency department: an analysis of direct costs

    Pharmacoepidemiology and Drug Safety

    Volume 24, Issue 2, February 2015, Pages: 176–186, Florian Meier, Renke Maas, Anja Sonst, Andrius Patapovas, Fabian Müller, Bettina Plank-Kiegele, Barbara Pfistermeister, Oliver Schöffski, Thomas Bürkle and Harald Dormann

    Article first published online : 17 JUN 2014, DOI: 10.1002/pds.3663

  2. Use of case–time–control design in pharmacovigilance applications: exploration with high-risk medications and unplanned hospital admissions in the Western Australian elderly

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 11, November 2013, Pages: 1159–1170, Sylvie D. Price, C. D'Arcy J. Holman, Frank M. Sanfilippo and Jon D. Emery

    Article first published online : 25 JUN 2013, DOI: 10.1002/pds.3469

  3. Disease risk score as a confounder summary method: systematic review and recommendations

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 2, February 2013, Pages: 122–129, Mina Tadrous, Joshua J. Gagne, Til Stürmer and Suzanne M. Cadarette

    Article first published online : 21 NOV 2012, DOI: 10.1002/pds.3377

  4. Terms used in patient safety related to medication: a literature review

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 8, August 2012, Pages: 799–809, Antonio Pintor-Mármol, María Isabel Baena, Paloma C. Fajardo, Daniel Sabater-Hernández, Loreto Sáez-Benito, María Victoria García-Cárdenas, Narjis Fikri-Benbrahim, Inés Azpilicueta and Maria José Faus

    Article first published online : 8 JUN 2012, DOI: 10.1002/pds.3296

  5. You have full text access to this OnlineOpen article
    Methodological gaps in the assessment of risk minimization interventions: a systematic review

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 6, June 2014, Pages: 572–579, Inna Gridchyna, Anne-Marie Cloutier, Lenhangmbong Nkeng, Camille Craig, Sarah Frise and Yola Moride

    Article first published online : 24 FEB 2014, DOI: 10.1002/pds.3596

  6. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and the risk of developing rheumatoid arthritis in antihypertensive drug users

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 8, August 2012, Pages: 835–843, Hilda J. I. de Jong, Rob J. Vandebriel, Siti R. F. Saldi, Liset van Dijk, Henk van Loveren, Jan Willem Cohen Tervaert and Olaf H. Klungel

    Article first published online : 6 JUN 2012, DOI: 10.1002/pds.3291

  7. Safety of saxagliptin: rationale for and design of a series of postmarketing observational studies

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 11, November 2012, Pages: 1202–1215, Vincent Lo Re III, Kevin Haynes, Eileen E. Ming, Jennifer Wood Ives, Laura N. Horne, Kimberly Fortier, Dena M. Carbonari, Sean Hennessy, Serena Cardillo, Peter P. Reese, K. Rajender Reddy, David Margolis, Andrea Apter, Stephen E. Kimmel, Jason Roy, Cristin P. Freeman, Hanieh Razzaghi, Crystal N. Holick, Daina B. Esposito, Tjeerd-Pieter Van Staa, Harshvinder Bhullar and Brian L. Strom

    Article first published online : 4 JUL 2012, DOI: 10.1002/pds.3318

  8. Balancing benefit and risk of medicines: a systematic review and classification of available methodologies

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 7, July 2014, Pages: 667–678, Shahrul Mt-Isa, Christine E. Hallgreen, Nan Wang, Torbjörn Callréus, Georgy Genov, Ian Hirsch, Stephen F. Hobbiger, Kimberley S. Hockley, Davide Luciani, Lawrence D. Phillips, George Quartey, Sinan B. Sarac, Isabelle Stoeckert, Ioanna Tzoulaki, Alain Micaleff, Deborah Ashby and On behalf of the IMI-PROTECT benefit–risk participants

    Article first published online : 13 MAY 2014, DOI: 10.1002/pds.3636

  9. Ophthalmic adverse drug reactions to systemic drugs: a systematic review

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 3, March 2014, Pages: 221–233, Ana Miguel, Filipe Henriques, Luís Filipe Azevedo and Altamiro Costa Pereira

    Article first published online : 27 JAN 2014, DOI: 10.1002/pds.3566

  10. Case-crossover study design in pharmacoepidemiology: systematic review and recommendations

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 11, November 2013, Pages: 1146–1153, Giulia P. Consiglio, Andrea M. Burden, Malcolm Maclure, Lisa McCarthy and Suzanne M. Cadarette

    Article first published online : 13 SEP 2013, DOI: 10.1002/pds.3508

  11. Off-label use of second generation antipsychotics for post-traumatic stress disorder in the Department of Veterans Affairs: time trends and sociodemographic, comorbidity, and regional correlates

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 1, January 2014, Pages: 77–86, Mark S. Bauer, Austin Lee, Mingfei Li, Laura Bajor, Ann Rasmusson and Lewis E. Kazis

    Article first published online : 31 AUG 2013, DOI: 10.1002/pds.3507

  12. Design of a score to identify hospitalized patients at risk of drug-related problems

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 9, September 2014, Pages: 923–932, Olatz Urbina, Olivia Ferrández, Santiago Grau, Sonia Luque, Sergi Mojal, Monica Marin-Casino, Javier Mateu-de-Antonio, Alexia Carmona, David Conde-Estévez, Merce Espona, Elena González, Marta Riu and Esther Salas

    Article first published online : 10 MAY 2014, DOI: 10.1002/pds.3634

  13. The non-linear threshold association between aspirin use and esophageal adenocarcinoma: results of a dose–response meta-analysis

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 3, March 2014, Pages: 278–284, Ye Xiaohua, Yao Zhenjiang, Liu Weidong, Xun Pengcheng and Chen Sidong

    Article first published online : 17 JAN 2014, DOI: 10.1002/pds.3560

  14. Measuring frailty using claims data for pharmacoepidemiologic studies of mortality in older adults: evidence and recommendations

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 9, September 2014, Pages: 891–901, Dae Hyun Kim and Sebastian Schneeweiss

    Article first published online : 24 JUN 2014, DOI: 10.1002/pds.3674

  15. Association between beta-interferon exposure and hospital events in multiple sclerosis

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 11, November 2014, Pages: 1213–1222, Charity Evans, Feng Zhu, Elaine Kingwell, Afsaneh Shirani, Mia L. van der Kop, John Petkau, Paul Gustafson, Yinshan Zhao, Joel Oger and Helen Tremlett

    Article first published online : 21 JUN 2014, DOI: 10.1002/pds.3667

  16. An observational study examining the effect of comorbidity on the rates of persistence and adherence to newly initiated oral anti-hyperglycaemic agents

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 12, December 2013, Pages: 1336–1344, Miriam P. O'Shea, Mary Teeling and Kathleen Bennett

    Article first published online : 21 OCT 2013, DOI: 10.1002/pds.3535

  17. Kidney function decline in metformin versus sulfonylurea initiators: assessment of time-dependent contribution of weight, blood pressure, and glycemic control

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 6, June 2013, Pages: 623–631, Adriana M. Hung, Christianne L. Roumie, Robert A. Greevy, Xulei Liu, Carlos G. Grijalva, Harvey J. Murff and Marie R. Griffin

    Article first published online : 17 APR 2013, DOI: 10.1002/pds.3432

  18. Variable selection on large case-crossover data: application to a registry-based study of prescription drugs and road traffic crashes

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 2, February 2014, Pages: 140–151, Marta Avalos, Ludivine Orriols, Hélène Pouyes, Yves Grandvalet, Frantz Thiessard, Emmanuel Lagarde and on behalf of the CESIR research group

    Article first published online : 18 OCT 2013, DOI: 10.1002/pds.3539

  19. Increasing use of atypical antipsychotics and anticonvulsants during pregnancy

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 7, July 2013, Pages: 794–801, Richard A. Epstein, William V. Bobo, Richard C. Shelton, Patrick G. Arbogast, James A. Morrow, Wei Wang, Rameela Chandrasekhar and William O. Cooper

    Article first published online : 5 NOV 2012, DOI: 10.1002/pds.3366

  20. Evaluation of a program of integrated care to reduce recurrent osteoporotic fractures

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 3, March 2013, Pages: 263–270, Lisa Goltz, Gabriel Degenhardt, Ulf Maywald, Wilhelm Kirch and Christoph Schindler

    Article first published online : 7 JAN 2013, DOI: 10.1002/pds.3399